OGXI

OncoGenex Pharmaceuticals Inc. News Headlines

$2.26
*  
0.17
7%
Get OGXI Alerts
*Delayed - data as of Oct. 30, 2014 14:02 ET  -  Find a broker to begin trading OGXI now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    OGXI Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
OncoGenex's Phase III Prostate Cancer Study Fully Enrolled - Analyst Blog
9/18/2014 5:11:00 PM - Zacks.com


OncoGenex Completes Patient Enrollment In Phase 3 Trial Of Custirsen
9/16/2014 6:42:00 AM - RTT News


OncoGenex's Custirsen Passes First Interim Futility Analysis - Analyst Blog
8/22/2014 5:40:00 PM - Zacks.com


Sector Update: Health Care Stocks Mixed; OncoGenex Pharmaceuticals Climbs After Cancer Drug Wins Fast-Track Designation
8/22/2014 12:47:28 PM - MT Newswires


Sector Update: Health Care
8/22/2014 12:46:48 PM - MT Newswires


OncoGenex Phase 3 ENSPIRIT Trial Continuing As Planned
8/22/2014 1:09:00 AM - RTT News


OncoGenex Q2 Loss Narrower than Expected, Revenues Down Y/Y - Analyst Blog
8/8/2014 4:00:00 PM - Zacks.com


OncoGenex Pharmaceuticals (OGXI) Soars: Stock Up 8.2% - Tale of the Tape
8/8/2014 9:39:00 AM - Zacks.com


OncoGenex Pharma Appoints John Bencich As VP And CFO
8/7/2014 7:02:00 AM - RTT News


OncoGenex's Apatorsen in Phase II for Lung Cancer - Analyst Blog
7/7/2014 4:30:00 PM - Zacks.com


Basket Of Biotech Bargains To Buy And Hold
6/30/2014 4:23:00 PM - Seeking Alpha


Moving Average Crossover Alert: OncoGenex (OGXI) - Tale of the Tape
5/21/2014 8:18:51 AM - Zacks.com


OncoGenex Posts Wider Loss, Beats Revenues - Analyst Blog
5/1/2014 5:20:01 PM - Zacks.com


Ironwood Up as Loss Narrows, Linzess Shines - Analyst Blog
4/30/2014 4:45:01 PM - Zacks.com


OncoGenex's Custirsen Misses Primary Endpoint - Analyst Blog
4/29/2014 6:29:01 PM - Zacks.com


OncoGenex: Phase III Trial In First Line Metastatic Prostate Cancer Fails, Now What?
4/28/2014 5:17:00 PM - Seeking Alpha


Monday Sector Laggards: Biotechnology, Education & Training Services
4/28/2014 3:53:32 PM - BNK Invest


Sector Update: Healthcare Stocks Flat to Higher Pre-Market; ONCOGenex Pharmaceuticals Down 48% on Synergy Phase 3 Results
4/28/2014 9:02:10 AM - MT Newswires


Sector Update: Healthcare
4/28/2014 9:01:45 AM - MT Newswires


OncoGenex Gains Fast Track Status for Custirsen - Analyst Blog
4/24/2014 6:50:01 PM - Zacks.com


Narrower-than-Expected Loss at OncoGenex - Analyst Blog
3/12/2014 1:34:01 PM - Zacks.com


Pipeline Progress at OncoGenex - Analyst Blog
2/13/2014 5:45:01 PM - Zacks.com


OncoGenex Pharmaceuticals (OGXI) Jumps: Stock Rises 5.8% - Tale of the Tape
2/11/2014 10:25:01 AM - Zacks.com


OncoGenex Pharmaceuticals (OGXI) Jumps: Stock Up 6.1% - Tale of the Tape
1/31/2014 10:39:01 AM - Zacks.com


OncoGenex Has A Potential Blockbuster Drug, But The Markets Are Pricing It Like An Orphan
1/28/2014 9:25:00 AM - Seeking Alpha